| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2025―Jan―16 |
Longitudinal cardiac imaging for assessment of myocardial injury in non-hospitalised community-dwelling individuals after COVID-19 infection: the Rotterdam Study |
Frederik van den Heuvel, Elif Aribas, Martijn J Tilly, Sven Geurts, Shuyue Yang, Zuolin Lu, Natasja M S de Groot, Annemien E van den Bosch, Thijs M H Eijsvogels, Robin Peeters, Frans Rutten, Geert-Jan Geersing, Joost van Rosmalen, M Arfan Ikram, Robin Nijveldt, Alexander Hirsch, Maryam Kavousi |
| 2 |
[GO] |
2024―Nov―14 |
Impact of the COVID-19 pandemic on incidence of coronary heart disease in Bavaria, Germany: an analysis of health claims data |
Florian Schederecker, Carolin T Lehner, Marian Eberl, Gunther Schauberger, Katharina Hansmann, Ewan Donnachie, Martin Tauscher, Adriana König, Leonie Sundmacher, Stefanie J Klug |
| 3 |
[GO] |
2024―Okt―11 |
The impact of COVID-19 vaccination on patients with congenital heart disease in England: a case-control study |
Catriona Harrison, Simon Frain, Farideh Jalalinajafabadi, Simon G Williams, Bernard Keavney |
| 4 |
[GO] |
2024―Mrz―13 |
The role of COVID-19 vaccines in preventing post-COVID-19 thromboembolic and cardiovascular complications |
Núria Mercadé-Besora, Xintong Li, Raivo Kolde, Nhung TH Trinh, Maria T Sanchez-Santos, Wai Yi Man, Elena Roel, Carlen Reyes, Antonella Delmestri, Hedvig M E Nordeng, Anneli Uusküla, Talita Duarte-Salles, Clara Prats, Daniel Prieto-Alhambra, Annika M Jödicke, Martí Català |
| 5 |
[GO] |
2023―Sep―07 |
Long-term cardiac follow-up of athletes infected with SARS-CoV-2 after resumption of elite-level sports |
Juliette C van Hattum, Joëlle J N Daems, Sjoerd M Verwijs, Leonoor V Wismans, Maarten A van Diepen, Maarten Groenink, S Matthijs Boekholdt, R Nils Planken, Adrienne van Randen, Alexander Hirsch, Maarten H Moen, Yigal M Pinto, Arthur A M Wilde, Harald T Jørstad |
| 6 |
[GO] |
2023―Jul―17 |
Non-COVID-19 cardiovascular pathology from return-to-play screening in college athletes after COVID-19 |
Christian F Klein, Bradley J Petek, Nathaniel Moulson, Aaron L Baggish, Timothy W Churchill, Kimberly G Harmon, Stephanie A Kliethermes, Manesh R Patel, Jonathan A Drezner |
| 7 |
[GO] |
2023―Mrz―27 |
Prevalence and diagnostic significance of de-novo 12-lead ECG changes after COVID-19 infection in elite soccer players |
Raghav T Bhatia, Aneil Malhotra, Hamish MacLachlan, Sabiha Gati, Sarandeep Marwaha, Nikhil Chatrath, Saad Fyyaz, Haroldo Aleixo, Samar Al-Turaihi, Aswin Babu, Joyee Basu, Paul Catterson, Robert Cooper, Joelle J N Daems, Harshil Dhutia, Filipe Ferrari, Juliette C van Hattum, Zafar Iqbal, Alexandros Kasiakogias, Antoinette Kenny, Tamim Khanbhai, Shafik Khoury, Chris Miles, David Oxborough, Kashif Quazi, Dhrubo Rakhit, Anushka Sharma, Amanda Varnava, Maria Teresa Tome Esteban, Gherardo Finocchiaro, Ricardo Stein, Harald T Jorstad, Michael Papadakis, Sanjay Sharma |
| 8 |
[GO] |
2023―Jan―13 |
Correspondence on “Electrocardiographic findings and prognostic values in patients hospitalised with COVID-19 in the World Heart Federation Global Study” by Pinto-Filhoet al |
Hamid Reza Marateb, Marjan Mansourian, Miguel Angel Mañanas |
| 9 |
[GO] |
2023―Jan―13 |
Response to: Correspondence on “Electrocardiographic findings and prognostic values in patients hospitalised with COVID-19 in the World Heart Federation Global Study” by Maratebet al |
Marcelo Martins Pinto-Filho, Carla P M Soares, Gabriela Miana Paixão, Antonio Luiz Pinho Ribeiro |
| 10 |
[GO] |
2023―Jan―06 |
Heartbeat: hospitalisation for COVID-19 is associated with an increased risk of subsequent adverse cardiovascular events |
Catherine M Otto |
| 11 |
[GO] |
2023―Jan―02 |
Response to: Correspondence on ‘Cardiovascular disease and mortality sequelae of COVID-19 in the UK Biobank’ by Jolobe |
Zahra Raisi-Estabragh, Nicholas C Harvey, Steffen E Petersen |
| 12 |
[GO] |
2023―Jan―02 |
Correspondence on ‘Cardiovascular disease and mortality sequelae of COVID-19 in the UK Biobank’ by Raisi-Estabraghet al |
Oscar Jolobe |
| 13 |
[GO] |
2022―Dez―12 |
COVID-19 international experience in paediatric patients with congenital heart disease |
Mary J Yeh, Lisa Bergersen, Kimberlee Gauvreau, Oliver M Barry, Sarosh P Batlivala, Elsa Bjornlund, Brian Boe, Luiz Fernando Caneo, Ulisses A Croti, Thomas Doyle, Shumaila Furnaz, Rodrigo Cesar Moraes, Michael L O'Byrne, Erica de Oliveira Paes, Alexis Palacios-Macedo, Dimitar Pechilkov, Nestor Fernando Sandoval, Supratim Sen, Mila Stajevic, Marco Antonio Ferreira Travessa, Kathy J Jenkins |
| 14 |
[GO] |
2022―Nov―25 |
Electrocardiographic findings and prognostic values in patients hospitalised with COVID-19 in the World Heart Federation Global Study |
Marcelo Martins Pinto-Filho, Gabriela Miana Paixão, Paulo Rodrigues Gomes, Carla P M Soares, Kavita Singh, Valentina Alice Rossi, Friedrich Thienemann, Charle Viljoen, Bishav Mohan, Nizal Sarrafzadegan, Abdul Wadud Chowdhury, Ntobeko Ntusi, Surender Deora, Pablo Perel, Dorairaj Prabhakaran, Karen Sliwa, Antonio Luiz Pinho Ribeiro |
| 15 |
[GO] |
2022―Okt―31 |
Cardiovascular disease and mortality sequelae of COVID-19 in the UK Biobank |
Zahra Raisi-Estabragh, Jackie Cooper, Ahmed Salih, Betty Raman, Aaron Mark Lee, Stefan Neubauer, Nicholas C. Harvey, Steffen E. Petersen |
| 16 |
[GO] |
2022―Okt―31 |
Not to be sneezed at: cardiovascular disease after COVID-19 infection |
Anda Bularga, David E Newby, Andrew R Chapman |
| 17 |
[GO] |
2022―Mrz―21 |
COVID-19: another reason for anticoagulation in patients with atrial fibrillation |
Pekka Raatikainen, Riitta Lassila |
| 18 |
[GO] |
2022―Mrz―10 |
Evaluation of antithrombotic use and COVID-19 outcomes in a nationwide atrial fibrillation cohort |
Alex Handy, Amitava Banerjee, Angela M Wood, Caroline Dale, Cathie L M Sudlow, Christopher Tomlinson, Daniel Bean, Johan H Thygesen, Mehrdad A Mizani, Michail Katsoulis, Rohan Takhar, Sam Hollings, Spiros Denaxas, Venexia Walker, Richard Dobson, Reecha Sofat |
| 19 |
[GO] |
2022―Feb―24 |
Heartbeat: delayed and inadequate treatment of acute coronary syndromes during the COVID-19 pandemic |
Catherine M Otto |
| 20 |
[GO] |
2022―Feb―10 |
Delayed cardiac repolarisation as a predictor of in-hospital mortality in patients with COVID-19 |
Joanna Fishbein, Kristie M Coleman, Amarbir Bhullar, Nikhil Sharma, Stefanos Zafeiropoulos, Umair Ansari, Tia Bimal, Yan Liu, Stavros E Mountantonakis |
| 21 |
[GO] |
2022―Feb―01 |
Changes in cardiovascular mortality in Chile during the COVID-19 pandemic |
Sheng-Wei Chang, Pedro Zitko, Álvaro Passi-Solar, Goodarz Danaei, Paula Margozzini |
| 22 |
[GO] |
2022―Jan―25 |
The STEMI phenomenon during the COVID-19 pandemic: what is beneath the tip of the iceberg? |
Victoria L. Cammann, Christian Templin |
| 23 |
[GO] |
2022―Jan―05 |
Allocating scarce cardiovascular support in a pandemic: ECMO in crisis standards of care |
Danish Zaidi, Savitri E Fedson, James N Kirkpatrick |
| 24 |
[GO] |
2021―Dez―22 |
Heartbeat: the role of antiplatelet therapy in treatment of COVID-19 infections |
Catherine M Otto |
| 25 |
[GO] |
2021―Dez―15 |
Impact of cardiometabolic multimorbidity and ethnicity on cardiovascular/renal complications in patients with COVID-19 |
Tom Norris, Cameron Razieh, Francesco Zaccardi, Thomas Yates, Nazrul Islam, Clare L Gillies, Yogini V Chudasama, Alex V Rowlands, Melanie J Davies, Gerry P McCann, Amitava Banerjee, Carolyn S P Lam, Annemarie B Docherty, Peter JM Openshaw, J Kenneth Baillie, Malcolm Gracie Semple, Claire Alexandra Lawson, Kamlesh Khunti |
| 26 |
[GO] |
2021―Nov―25 |
CardioWebinar: the evolution of digital education during the COVID-19 pandemic |
Balrik Singh Kailey, Damanpreet Dev, Daniel M Sado, Vishal Luther |
| 27 |
[GO] |
2021―Okt―28 |
COVID-19 pandemic, mechanical reperfusion and 30-day mortality in ST elevation myocardial infarction |
Giuseppe De Luca, Magdy Algowhary, Berat Uguz, Dinaldo C Oliveira, Vladimir Ganyukov, Zan Zimbakov, Miha Cercek, Lisette Okkels Jensen, Poay Huan Loh, Lucian Calmac, Gerard Roura-Ferrer, Alexandre Quadros, Marek Milewski, Fortunato Scotto di Uccio, Clemens von Birgelen, Francesco Versaci, Jurriën Ten Berg, Gianni Casella, Aaron Sung Lung Wong, Petr Kala, Jose Luis Diez Gil, Xavier Carrillo, Maurits Theodoor Dirksen, Víctor Manuel Becerra-Muñoz, Michael Kang-yin Lee, Dafsah A Juzar, Rodrigo de Moura Joaquim, Roberto Paladino, Davor Milicic, Periklis Davlouros, Nikola Bakraceski, Filippo Zilio, Luca Donazzan, Adriaan O Kraaijeveld, Gennaro Galasso, Arpad Lux, Lucia Marinucci, Vincenzo Guiducci, Maurizio Menichelli, Alessandra Scoccia, Aylin Yamac, Kadir Ugur Mert, Xacobe Flores Rios, Tomas Kovarnik, Michal Kidawa, Jose Moreu, Vincent Flavien, Enrico Fabris, Iñigo Lozano Martìnez-Luengas, Marco Boccalatte, Francisco Bosa Ojeda, Carlos Arellano-Serrano, Gianluca Caiazzo, Giuseppe Cirrincione, Hsien-Li Kao, Juan Sanchis Fores, Luigi Vignali, Helder Pereira, Stéphane Manzo-Silberman, Santiago Ordonez, Alev Arat Özkan, Bruno Scheller, Heidi Lehtola, Rui Teles, Christos Mantis, Antti Ylitalo, Joao Antonio Brum Silveira, Rodrigo Zoni, Ivan Bessonov, Stefano Savonitto, George Kochiadakis, Dimitrios Alexopoulos, Carlos Uribe, John Kanakakis, Benjamin Faurie, Gabriele Gabrielli, Alejandro Gutiérrez, Juan Pablo Bachini, Alex Rocha, Franckie CC Tam, Alfredo Rodriguez, Antonia Lukito, Veauthyelau Saint-Joy, Gustavo Pessah, Bernardino Tuccillo, Giuliana Cortese, Guido Parodi, Mohamed Abed Bouraghda, Elvin Kedhi, Pablo Lamelas, Harry Suryapranata, Matteo Nardin, Monica Verdoia |
| 28 |
[GO] |
2021―Okt―16 |
Cardiac involvement in COVID-19: cause or consequence of severe manifestations? |
Bruno Ramos Nascimento, Craig Sable |
| 29 |
[GO] |
2021―Okt―16 |
Does aspirin save lives in patients with COVID-19? |
Dinesh Voruganti, Pier Paolo Bassareo, Giuseppe Calcaterra, J L Mehta |
| 30 |
[GO] |
2021―Okt―13 |
MRI and CT coronary angiography in survivors of COVID-19 |
Trisha Singh, Thomas A Kite, Shruti S Joshi, Nick B Spath, Lucy Kershaw, Andrew Baker, Helen Jordan, Gaurav Singh Gulsin, Michelle Claire Williams, Edwin J R van Beek, Jayanth Ranjit Arnold, Scott I K Semple, Alastair James Moss, David E Newby, Marc Dweck, Gerry P McCann |
| 31 |
[GO] |
2021―Okt―11 |
ST elevation in a critically ill patient with COVID-19: what is the emergency treatment? |
Mohamad Al Raqabani, Anas Mohmoud Musa, Omar Yousef Al-assaf |
| 32 |
[GO] |
2021―Okt―05 |
Antiplatelet therapy and outcome in COVID-19: the Health Outcome Predictive Evaluation Registry |
Francesco Santoro, Ivan Javier Nuñez-Gil, Enrica Vitale, Maria C Viana-Llamas, Begoña Reche-Martinez, Rodolfo Romero-Pareja, Gisela Feltez Guzman, Inmaculada Fernandez Rozas, Aitor Uribarri, Víctor Manuel Becerra-Muñoz, Emilio Alfonso-Rodriguez, Marcos Garcia-Aguado, Jia Huang, María Elizabeth Ortega-Armas, Juan F Garcia Prieto, Eva Maria Corral Rubio, Fabrizio Ugo, Matteo Bianco, Alba Mulet, Sergio Raposeiras-Roubin, Jorge Luis Jativa Mendez, Carolina Espejo Paeres, Adrián Rodríguez Albarrán, Francisco Marín, Federico Guerra, Ibrahim Akin, Bernardo Cortese, Harish Ramakrishna, Carlos Macaya, Antonio Fernandez-Ortiz, Natale Daniele Brunetti |
| 33 |
[GO] |
2021―Apr―16 |
Anatomical complexity does not predict outcomes after COVID-19 in adults with congenital heart disease |
Su Yuan, Erwin Oechslin |
| 34 |
[GO] |
2021―Mrz―09 |
Racial differences in management and outcomes of acute myocardial infarction during COVID-19 pandemic |
Muhammad Rashid, Adam Timmis, Tim Kinnaird, Nick Curzen, Azfar Zaman, Ahmad Shoaib, Mohamed O Mohamed, Mark A de Belder, John Deanfield, Glen Philip Martin, Jianhua Wu, Chris P Gale, Mamas Mamas |
| 35 |
[GO] |
2021―Mrz―09 |
To be, or not to be BAME, in the time of COVID-19: does it matter? |
F Aaysha Cader, Clyde W Yancy, Shrilla Banerjee |
| 36 |
[GO] |
2021―Mrz―08 |
Clinical outcome of COVID-19 in patients with adult congenital heart disease |
Markus Schwerzmann, Francisco Javier Ruperti-Repilado, Helmut Baumgartner, Berto Bouma, Judith Bouchardy, Werner Budts, Laurence Campens, Massimo Chessa, Maria Jesús del Cerro Marin, Harald Gabriel, Pastora Gallego, Rocio Garcia-Orta, Ana Elvira Gonzalez, Annette Schophuus Jensen, Magalie Ladouceur, Berta Miranda-Barrio, Marielle Morissens, Agnes Pasquet, Joaquín Rueda, Annemien E van den Bosch, Heleen Berdina van der Zwaan, Daniel Tobler, Matthias Greutmann |
| 37 |
[GO] |
2021―Feb―11 |
Heartbeat: higher risk of COVID-19 infection in younger patients with cardiovascular disease |
Catherine M Otto |
| 38 |
[GO] |
2021―Feb―01 |
COVID-19 pandemic: preventing hospital myocardial infarction admissions or preventing acute myocardial infarction altogether? |
Nicolas Danchin, Eloi Marijon |
| 39 |
[GO] |
2021―Jan―15 |
Socioeconomic status and cardiovascular health in the COVID-19 pandemic |
Jeremy Naylor-Wardle, Ben Rowland, Vijay Kunadian |
| 40 |
[GO] |
2021―Jan―12 |
Remote monitoring in heart failure: current and emerging technologies in the context of the pandemic |
Donya Mohebali, Michelle M Kittleson |
| 41 |
[GO] |
2021―Jan―11 |
Heartbeat: the COVID-19 pandemic and the future of cardiology |
Catherine M Otto |
| 42 |
[GO] |
2021―Jan―09 |
If not now, when? Enhancing cardiologists’ psychological well-being as a COVID-19 gain |
Rishi K Patel, Mark D Sweeney, Christopher S R Baker, Neil Greenberg, Susan E Piper, Sukhi S Shergill, Derek K Tracy, Carla M Plymen |
| 43 |
[GO] |
2020―Dez―23 |
Impact of cardiovascular disease and risk factors on fatal outcomes in patients with COVID-19 according to age: a systematic review and meta-analysis |
SungA Bae, So Ree Kim, Mi-Na Kim, Wan Joo Shim, Seong-Mi Park |
| 44 |
[GO] |
2020―Dez―23 |
Heartbeat: an increase in preventable cardiovascular deaths during the COVID-19 pandemic due to avoidance of medical care |
Catherine M Otto |
| 45 |
[GO] |
2020―Dez―23 |
Effect of the COVID-19 pandemic on mortality of patients with STEMI: a systematic review and meta-analysis |
Manuel Rattka, Jens Dreyhaupt, Claudia Winsauer, Lina Stuhler, Michael Baumhardt, Kevin Thiessen, Wolfgang Rottbauer, Armin Imhof |
| 46 |
[GO] |
2020―Dez―11 |
Antihypertensive drugs and COVID-19 |
David Henry |
| 47 |
[GO] |
2020―Nov―26 |
Heartbeat: cardiovascular health in the time of COVID-19 |
Catherine M Otto |
| 48 |
[GO] |
2020―Nov―10 |
Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people |
Julia Hippisley-Cox, Pui San Tan, Carol Coupland |
| 49 |
[GO] |
2020―Nov―05 |
Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people |
Julia Hippisley-Cox, Pui San Tan, Carol Coupland |
| 50 |
[GO] |
2020―Nov―04 |
Risk of COVID-19 and smoking |
Ivan Berlin |
| 51 |
[GO] |
2020―Nov―03 |
Cardiovascular health and COVID-19: time to reinvent our systems and rethink our research priorities |
David A Watkins |
| 52 |
[GO] |
2020―Okt―21 |
COVID-19 pandemic and infarctions: another call to reorganise our healthcare systems |
Ovidio De Filippo, Fabrizio D'Ascenzo, Gaetano Maria Deferrari |
| 53 |
[GO] |
2020―Okt―15 |
Excess of cardiovascular deaths during the COVID-19 pandemic in Brazilian capital cities |
Luisa Campos Caldeira Brant, Bruno Ramos Nascimento, Renato Azeredo Teixeira, Marcelo Antônio Cartaxo Queiroga Lopes, Deborah Carvalho Malta, Glaucia Maria Moraes Oliveira, Antonio Luiz Pinho Ribeiro |
| 54 |
[GO] |
2020―Okt―14 |
Integrated clinical role of echocardiography in patients with COVID-19 |
Matteo Pagnesi, Luca Baldetti, Alessandro Beneduce, Francesco Calvo, Mario Gramegna, Vittorio Pazzanese, Giacomo Ingallina, Antonio Napolano, Renato Finazzi, Annalisa Ruggeri, Silvia Ajello, Giulio Melisurgo, Paolo Guido Camici, Paolo Scarpellini, Moreno Tresoldi, Giovanni Landoni, Fabio Ciceri, Anna Mara Scandroglio, Eustachio Agricola, Alberto Maria Cappelletti |
| 55 |
[GO] |
2020―Okt―14 |
Integrated clinical role of echocardiography in patients with COVID-19 disease |
Chiara Lazzeri, Manuela Bonizzoli, Adriano Peris |
| 56 |
[GO] |
2020―Okt―14 |
Cardiac catheterisation laboratory in a global pandemic: ceding centre stage |
Rong Bing, Philip D Adamson |
| 57 |
[GO] |
2020―Okt―06 |
Incidence and outcome of myocardial infarction treated with percutaneous coronary intervention during COVID-19 pandemic |
Moman A Mohammad, Sasha Koul, Göran K Olivecrona, Matthias Gӧtberg, Patrik Tydén, Erik Rydberg, Fredrik Scherstén, Joakim Alfredsson, Peter Vasko, Elmir Omerovic, Oskar Angerås, Ole Fröbert, Fredrik Calais, Sebastian Völz, Anders Ulvenstam, Dimitrios Venetsanos, Troels Yndigegn, Jonas Oldgren, Giovanna Sarno, Per Grimfjärd, Jonas Persson, Nils Witt, Ellen Ostenfeld, Bertil Lindahl, Stefan K James, David Erlinge |
| 58 |
[GO] |
2020―Okt―05 |
Monitoring indirect impact of COVID-19 pandemic on services for cardiovascular diseases in the UK |
Simon Ball, Amitava Banerjee, Colin Berry, Jonathan Boyle, Benjamin Bray, William Bradlow, Afzal Chaudhry, Rikki Crawley, John Danesh, Alastair Denniston, Florian Falter, Jonine D Figueroa, Christopher Hall, Harry Hemingway, Emily Jefferson, Tom Johnson, Graham King, Kuan Ken Lee, Paul McKean, Suzanne Mason, Nicholas L Mills, Ewen Pearson, Munir Pirmohamed, Michael T C Poon, Rouven Priedon, Anoop Shah, Reecha Sofat, Jonathan A C Sterne, Fiona E Strachan, Cathie L M Sudlow, Zsolt Szarka, William Whiteley, Michael Wyatt |
| 59 |
[GO] |
2020―Sep―28 |
Place and causes of acute cardiovascular mortality during the COVID-19 pandemic |
Jianhua Wu, Mamas A Mamas, Mohamed O Mohamed, Chun Shing Kwok, Chris Roebuck, Ben Humberstone, Tom Denwood, Thomas Luescher, Mark A de Belder, John E Deanfield, Chris P Gale |
| 60 |
[GO] |
2020―Sep―14 |
Heartbeat: interaction of renin-angiotensin-aldosterone blocking drugs with COVID-19 disease susceptibility and severity |
Catherine M Otto |
| 61 |
[GO] |
2020―Sep―02 |
Optimal management of acute coronary syndromes in the era of COVID-19 |
Sukhjinder Singh Nijjer, Ricardo Petraco, Sayan Sen |
| 62 |
[GO] |
2020―Aug―31 |
Impact of COVID-19 on percutaneous coronary intervention for ST-elevation myocardial infarction |
Chun Shing Kwok, Chris P Gale, Tim Kinnaird, Nick Curzen, Peter Ludman, Evan Kontopantelis, Jianhua Wu, Tom Denwood, Nadeem Fazal, John Deanfield, Mark A de Belder, Mamas Mamas |
| 63 |
[GO] |
2020―Aug―31 |
Outpatient management of heart valve disease following the COVID-19 pandemic: implications for present and future care |
Benoy Nalin Shah, Dominik Schlosshan, Hannah Zelie Ruth McConkey, Mamta Heena Buch, Andrew John Marshall, Neil Cartwright, Laura Elizabeth Dobson, Christopher Allen, Brian Campbell, Patricia Khan, Peter John Savill, Norman Paul Briffa, John Boyd Chambers |
| 64 |
[GO] |
2020―Aug―14 |
Early detection of elevated cardiac biomarkers to optimise risk stratification in patients with COVID-19 |
Giulio G. Stefanini, Mauro Chiarito, Giuseppe Ferrante, Francesco Cannata, Elena Azzolini, Giacomo Viggiani, Andrea De Marco, Martina Briani, Monica Bocciolone, Renato Bragato, Elena Corrada, Gabriele L Gasparini, Manuel Marconi, Lorenzo Monti, Paolo A Pagnotta, Cristina Panico, Daniela Pini, Damiano Regazzoli, Ilaria My, Marinos Kallikourdis, Michele Ciccarelli, Salvatore Badalamenti, Alessio Aghemo, Bernhard Reimers, Gianluigi Condorelli |
| 65 |
[GO] |
2020―Aug―12 |
Heartbeat: taking care of patients with cardiovascular disease during a pandemic |
Catherine M Otto |
| 66 |
[GO] |
2020―Aug―05 |
Observational data during the COVID-19 pandemic: opportunity with uncertainty |
Sam Straw, Klaus K Witte |
| 67 |
[GO] |
2020―Jul―31 |
Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people |
Julia Hippisley-Cox, Duncan Young, Carol Coupland, Keith M Channon, Pui San Tan, David A Harrison, Kathryn Rowan, Paul Aveyard, Ian D Pavord, Peter J Watkinson |
| 68 |
[GO] |
2020―Jul―22 |
Heartbeat: Heart disease and COVID-19 |
Catherine M Otto |
| 69 |
[GO] |
2020―Jul―16 |
Pulmonary hypertension and right ventricular involvement in hospitalised patients with COVID-19 |
Matteo Pagnesi, Luca Baldetti, Alessandro Beneduce, Francesco Calvo, Mario Gramegna, Vittorio Pazzanese, Giacomo Ingallina, Antonio Napolano, Renato Finazzi, Annalisa Ruggeri, Silvia Ajello, Giulio Melisurgo, Paolo Guido Camici, Paolo Scarpellini, Moreno Tresoldi, Giovanni Landoni, Fabio Ciceri, Anna Mara Scandroglio, Eustachio Agricola, Alberto Maria Cappelletti |
| 70 |
[GO] |
2020―Jul―03 |
COVID-19 and acute myocardial injury: the heart of the matter or an innocent bystander? |
Richard Cheng, Douglas Leedy |
| 71 |
[GO] |
2020―Jul―02 |
Treatment with ACE inhibitors or ARBs and risk of severe/lethal COVID-19: a meta-analysis |
Maria Elena Flacco, Cecilia Acuti Martellucci, Francesca Bravi, Giustino Parruti, Rosaria Cappadona, Alfonso Mascitelli, Roberto Manfredini, Lorenzo G Mantovani, Lamberto Manzoli |
| 72 |
[GO] |
2020―Jun―11 |
Acute myocardial injury is common in patients with covid-19 and impairs their prognosis |
Jia-Fu Wei, Fang-Yang Huang, Tian-Yuan Xiong, Qi Liu, Hong Chen, Hui Wang, He Huang, Yi-Chun Luo, Xuan Zhou, Zhi-Yue Liu, Yong Peng, Yuan-Ning Xu, Bo Wang, Ying-Ying Yang, Zong-An Liang, Xue-Zhong Lei, Yang Ge, Ming Yang, Ling Zhang, Ming-Quan Zeng, He Yu, Kai Liu, Yu-Heng Jia, Bernard D Prendergast, Wei-Min Li, Mao Chen |
| 73 |
[GO] |
2020―Jun―10 |
Adult congenital heart disease and the COVID-19 pandemic |
Robert M Radke, Tim Frenzel, Helmut Baumgartner, Gerhard-Paul Diller |
| 74 |
[GO] |
2020―Jun―10 |
Transcatheter management of severe aortic stenosis during the COVID-19 pandemic |
Bharat Khialani, Philip MacCarthy |
| 75 |
[GO] |
2020―Jun―04 |
COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis? |
Massimo Imazio, Karin Klingel, Ingrid Kindermann, Antonio Brucato, Francesco Giuseppe De Rosa, Yehuda Adler, Gaetano Maria De Ferrari |
| 76 |
[GO] |
2020―Mai―27 |
Getting to the heart of the matter of COVID-19 |
David E Newby, Kazem Rahimi |
| 77 |
[GO] |
2020―Mai―27 |
Impact of cardiovascular disease and cardiac injury on in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis |
Xintao Li, Bo Guan, Tong Su, Wei Liu, Mengyao Chen, Khalid Bin Waleed, Xumin Guan, Tse Gary, Zhenyan Zhu |
| 78 |
[GO] |
2020―Mai―25 |
Cardiovascular disease and COVID-19: implications for prevention, surveillance and treatment |
Neal A Chatterjee, Richard K Cheng |
| 79 |
[GO] |
2020―Mai―25 |
Do underlying cardiovascular diseases have any impact on hospitalised patients with COVID-19? |
Jixiang Zhang, Shimin Lu, Xiaoli Wang, Xuemei Jia, Jiao Li, Hongbo Lei, Zhengru Liu, Fei Liao, Mengyao Ji, Xiaoguang Lv, Jian Kang, Shan Tian, Jingjing Ma, Dandan Wu, Yang Gong, Yu Xu, Weiguo Dong |
| 80 |
[GO] |
2020―Mai―22 |
Challenges in the management of older patients with acute coronary syndromes in the COVID-19 pandemic |
Ben Rowland, Vijay Kunadian |
| 81 |
[GO] |
2020―Mai―12 |
Flattening the curve in COVID-19 using personalised protective equipment: lessons from air pollution |
Sanjay Rajagopaian, Sui Huang, Robert D Brook |
| 82 |
[GO] |
2020―Apr―30 |
Cardiovascular manifestations and treatment considerations in covid-19 |
Yu Kang, Tiffany Chen, David Mui, Victor Ferrari, Dinesh Jagasia, Marielle Scherrer-Crosbie, Yucheng Chen, Yuchi Han |
|
